The role of mesenchymal stem cells in maintenance and repair of bone
- PMID: 17383482
- DOI: 10.1016/j.injury.2007.02.007
The role of mesenchymal stem cells in maintenance and repair of bone
Abstract
The maintenance of stable bone mass during adult life, following rapid skeletal growth during childhood, is the result of a carefully controlled balance between the activities of bone forming (osteoblast) and bone resorbing (osteoclast) cells. Although skeletal turnover continues throughout adult life, the net effect of formation and resorption on bone mass is zero in healthy individuals. Later in life, bone mass begins to fall as resorption outpaces formation, particularly in post-menopausal women, which leads to increased fracture risk. The opposing actions of these two cell types are coupled by molecular interactions between them that are thought to be influenced by the actions of the precursor cells of the osteoblast lineage, mesenchymal stem cells (MSCs). In addition to regulating normal skeletal homeostasis, MSCs also play an important role in fracture repair. Bone fracture or injury initiates a series of cellular and molecular pathways that commence with hematoma formation and an inflammatory cascade that regulates MSCs activity leading to fracture healing and the reestablishment of skeletal integrity. Although tremendous strides have been made in increasing our understanding of bone biology, there is surprisingly little data about the role of MSCs in vivo in the maintenance of skeletal integrity or fracture repair. In recent years, the pivotal importance of anabolic therapies in the setting of osteoporosis in which bone mass is substantially increased above and beyond what is attainable with the bisphosphonate class of drugs has put MSC biology firmly on the scientific agenda. Although the biology of cultured MSCs is reasonably well understood, the biology of MSCs in vivo in both bone turnover and fracture repair remains poorly understood. The recent phenotypic characterization of in vivo MSCs and the ability to prospectively purify such cells will open up new avenues of research into a better understanding of the role of MSCs in bone turnover. The purpose of this article is to review bone and fracture biology from the perspective of recent advances in our understanding of MSCs and to highlight the major deficiencies in our current knowledge.
Similar articles
-
Mesenchymal stem cells and bone regeneration: current status.Injury. 2011 Jun;42(6):562-8. doi: 10.1016/j.injury.2011.03.030. Epub 2011 Apr 13. Injury. 2011. PMID: 21489533 Review.
-
[Mesenchymal stem cells. Potential use in cell and gene therapy of bone loss caused by aging and osteoporosis].Ugeskr Laeger. 2001 Oct 1;163(40):5491-5. Ugeskr Laeger. 2001. PMID: 11601113 Review. Danish.
-
Current concepts of molecular aspects of bone healing.Injury. 2005 Dec;36(12):1392-404. doi: 10.1016/j.injury.2005.07.019. Epub 2005 Aug 15. Injury. 2005. PMID: 16102764 Review.
-
The clinical use of enriched bone marrow stem cells combined with porous beta-tricalcium phosphate in posterior spinal fusion.Biomaterials. 2008 Oct;29(29):3973-82. doi: 10.1016/j.biomaterials.2008.06.026. Epub 2008 Jul 18. Biomaterials. 2008. PMID: 18639333 Clinical Trial.
-
Skeletal stem/osteoprogenitor cells: current concepts, alternate hypotheses, and relationship to the bone remodeling compartment.J Cell Biochem. 2008 Feb 1;103(2):393-400. doi: 10.1002/jcb.21423. J Cell Biochem. 2008. PMID: 17541947 Review.
Cited by
-
Osteogenic effects of dedifferentiated fat cell transplantation in rabbit models of bone defect and ovariectomy-induced osteoporosis.Tissue Eng Part A. 2013 Aug;19(15-16):1792-802. doi: 10.1089/ten.TEA.2012.0380. Epub 2013 May 15. Tissue Eng Part A. 2013. PMID: 23566022 Free PMC article.
-
Human Adipose-Derived Mesenchymal Stem Cells-Incorporated Silk Fibroin as a Potential Bio-Scaffold in Guiding Bone Regeneration.Polymers (Basel). 2020 Apr 7;12(4):853. doi: 10.3390/polym12040853. Polymers (Basel). 2020. PMID: 32272682 Free PMC article.
-
Neoplastic bone marrow niche: hematopoietic and mesenchymal stem cells.Cell J. 2011 Fall;13(3):131-6. Epub 2011 Sep 23. Cell J. 2011. PMID: 23508881 Free PMC article.
-
MC3T3-E1 osteoprogenitor cells systemically migrate to a bone defect and enhance bone healing.Tissue Eng Part A. 2012 May;18(9-10):968-73. doi: 10.1089/ten.TEA.2011.0545. Epub 2012 Jan 4. Tissue Eng Part A. 2012. PMID: 22129134 Free PMC article.
-
Platelet lysate for expansion or osteogenic differentiation of bone marrow mesenchymal stem cells for 3D tissue constructs.Regen Ther. 2023 Aug 11;24:298-310. doi: 10.1016/j.reth.2023.07.011. eCollection 2023 Dec. Regen Ther. 2023. PMID: 37588134 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical